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T 
he TCR repertoire, initially generated by random re- 
arrangement of TCR ot and [3 loci, is heavily shaped 
by the thymic selection processes. CD4+CD8 + thymocytes 
expressing TCRs that will in the peripheral lymphoid tissue 
recognize foreign antigens presented by self MHC are de- 
livered survival and possibly differentiation signals  by self 
peptide/self MHC complexes in the thymus (1). This pro- 
cess,  known as positive selection, is also  associated with a 
commitment of CD4+CD8 + thymocytes to the CD4+CD8 - 
or CD4-CD8 + lineage. Remaining thymocytes expressing 
TCRs not reactive with self peptide/MHC complexes are 
thought to die by default. In both cases of cell death in the 
thymus (peptide/MHC-induced or by default), thymocytes 
die  by  apoptosis  (2).  In  addition,  thymocytes expressing 
TCRs with potentially harmful reactivity with selfpeptide/ 
MHC must be silenced or eliminated. This process of neg- 
ative selection can be achieved by physical deletion (3-5) 
or by  a  variety of non-deletional mechanisms,  including 
down-modulating the levels of coreceptor molecules (4, 6), 
rendering  cells  anergic  (7,  8),  or  raising  the  activation 
thresholds in T  cells (9). 
One of the approaches to understand the apparent para- 
dox of how the interaction of the same TCR with the self 
peptide/MHC complexes can result in two profoundly dif- 
ferent  outcomes  (positive  or  negative  selection)  was  to 
identify the cells in the thymus responsible for inducing the 
selection processes. Evidence for the major role of thymic 
epithelium in promoting positive selection is overwhelm- 
ing.  Early bone marrow chimera and thymus transplanta- 
tion experiments have established that the MHC restriction 
pattern  of antigen recognition in  the  periphery was  effi- 
ciently imprinted by thymic epithelial cells (10-14). Subse- 
quently, transgenic mice with limited tissue  expression of 
the MHC class II have established the thymic cortex as the 
selection site  (15).  Thymus reaggregation cultures demon- 
strated convincingly that  cortical epithelial cells were ex- 
clusively required  for  the  conversion  of CD4+CD8 +  to 
CD4-CD8 + or CD4+CD8 -  thymocytes (16,  17).  Finally, 
long-term thymic epithelial cell lines were shown to im- 
print new MHC restriction patterns of antigen recognition 
after intrathymic injection (18,  19). 
Recently,  evidence  demonstrating  the  ability  of other 
cell types to induce positive selection has accumulated. Fibro- 
blast cell lines injected intrathymicly were shown to induce 
positive selection (20,  21).  In nude mice cells of unknown 
origin, but apparently non-thymic residents, imprinted re- 
striction of T cells to the host MHC haplotype. This MHC 
restriction pattern could only be detected after transfer of a 
mixture of bone  marrow and  spleen  cells  to MHC  mis- 
matched SCID recipients to allow full maturation ofT cells 
(22). Finally, wild-type bone marrow-derived cells can rel- 
atively inefficiently impose an MHC restriction pattern on 
themselves in MHC class I-deficient mice (23).  Thus, un- 
der certain experimental conditions cells of non-epithelial 
origin  may  induce  positive  selection,  but  epithelial  cells 
seem the most effcient, and in many cases the only, pro- 
moters of positive selection. 
Early experiments assessing the capacity to induce toler- 
ance suggested that bone marrow-derived, but not thymic 
epithelial cells can induce tolerance to MHC (24, 25). This 
was supported by findings that thymic epithelial cells could 
not induce deletion of particular TCR V[3 expressing thy- 
mocytes that were readily deleted by the bone marrow de- 
rived cells (26).  However, the ability of thymic epithelium 
to induce tolerance remained controversial, as reports accu- 
mulated suggesting that tolerance to defined peptide anti- 
gens  or  minor  histocompatibility  complex  antigens  (27, 
28), as well as partial tolerance to major histocompatibility 
antigens  (8,  29,  30)  could be induced by thymic epithe- 
lium. Recent studies have demonstrated tolerance induced 
by thymic epithelium is complete with respect to the thy- 
mic stromal tissue  itself, i.e., tolerized mice accept thymus 
grafts,  but reject other tissues  (31).  These findings suggest 
that the lack of tolerance observed in some cases was due to 
differences in the peptides expressed by tolerazing thymic 
epithehal cells and skin grafts or bone marrow-derived cells 
used as stimulators in in vitro assays of tolerance. In addi- 
tion, lack of expression of superantigens (sAg), revealed ei- 
ther by the inability of thymic epithelial cells to stimulate 
sAg-reactive T  cell hybridomas (32),  or by the lack of spe- 
cific mRNA expression (33), might explain the inability of 
thymic  epithelial cells  to  induce  deletion of sAg-reactive 
V[3 TCRs (26, 32, 34). In an in vitro deletion assay, a vari- 
ety of cell types induced deletion of CD4+CD8 + thymo- 
cytes (35), including the thymic epithelial cell lines that also 
induced positive selection (36, 37). It can be therefore con- 
cluded that the ability to induce tolerance is not unique to 
any particular cell type in or outside the thymus. Still, bone 
marrow-derived cells may be more efficient since they in- 
duce deletion of CD4+CD8 § thymocytes whereas thymic 
epithelial cells induce non-deletional tolerance (38, 39). 
In this issue  Kishimoto et al.  (40)  describe experiments 
that may offer a molecular basis for distinct roles of thymic 
epithelial and bone marrow-derived cells in thymic selec- 
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Volume 184  August 1996 305-309 tion  events.  The  authors  determined  survival  and  death 
rates in suspension cultures of CD4+CD8 + thymocytes ex- 
pressing the  transgenic  2C  TC1L,  specific for e~-ketoglu- 
tarate dehydrogenase-derived octamer (p2Ca)  or nonamer 
(QL9)  peptides presented by H-2L  a (41).  The affinity of 
the  2C  TCR for the  H-2L  a complexed to p2Ca is  rela- 
tively high (K  M =  2 ￿  106 M-~) whereas the affinity for the 
H-2L  a complexed to QL9 is even higher (KM =  1-2 ￿  107 
M-')  (42,  43).  2C  CD4+CD8 +  thymocytes were  stimu- 
lated by either of the peptides presented by Drosophila cells 
expressing H-2L  d alone, or coexpressing adhesion/costim- 
ulatory molecules ICAM-1, B7.1, or both. In the absence 
of either adhesion molecule on Drosophila cells, only QL9 
could induce apoptosis. The expression of B7.1  molecule 
enhanced the apoptosis induced by QL9. In addition, p2Ca 
induced apoptosis as well in the presence of B7.1. The ex- 
pression  of both B7.1  and ICAM-1  increased further the 
death rate induced by both peptides. Surprisingly, expres- 
sion of the ICAM-1  in the absence of B7.1  inhibited the 
low levels of apoptosis  induced by QL9,  despite  the  fact 
that CD4+CD8 + cells were significantly activated as deter- 
mined by the induction of CD69  expression.  The results 
suggest a direct relationship between the strength of extra- 
cellular stimulation of CD4+CD8 + cells (defined as a sum 
of avidities of different intercellular interactions),  and  the 
induction ofapoptosis. If the TCR recognizes peptide with 
a  relatively higher  binding  affinity,  apoptosis  can  be  in- 
duced without costimulation. Additional adhesion/costim- 
ulatory interactions further enhance the apoptotic response. 
However, the protective effect of ICAM-1 against  apopto- 
sis induced by QL9 peptide suggests that the strength ofex- 
tracellular stimulation is not the sole factor determining the 
fate of CD4+CD8 + cells, and that the quality of the signal 
(likely related to the use of specific intracellular activation 
pathways) is also important. 
How do these findings from in vitro deletion assay apply 
to selection in the  thymus? The patterns  of the ICAM-1 
and B7.1 molecule expression in the thymus are very sug- 
gestive  (44,  45).  Cortical epithefial cells  express ICAM-1, 
but not B7.1. By contrast, both B7.1 and ICAM-1 are ex- 
pressed  in  the  medulla  by bone  marrow-derived cells  as 
well as medullary epithelium. Despite tissue specific expres- 
sion  of some  peptides  (31),  most  MHC-bound  peptides 
seem to be  shared by positively selecting epithelium and 
bone marrow-derived cells  (46,  47).  If the in vitro studies 
apply to the in vivo situation, then one can envisage several 
outcomes  of thymic  selection  with  the  involvement  of 
same peptides expressed by different cell types (Fig.  1). As 
mentioned earlier, positive selection probably reflects more 
than just a survival signal  (1) and it is not clear at this point 
whether survival of cells in the in vitro assay performed by 
Kishimoto  et  al.  represents  positive  selection,  non-dele- 
tional tolerance, or both. Since virtually all cells in the thy- 
mus express ICAM-1  (44), stimulation with peptide/MHC 
complex alone  does  not  occur in  vivo.  Therefore, there 
may be a positive correlation between the  signal  strength 
and the fate ofCD4+CD8 + cells, as illustrated in Fig.  1. 
Which molecular interactions contribute to the signal re- 
ceived  by  CD4+CD8 + thymocytes? Different presenting 
cells in the thymus may directly affect the signal  delivered 
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Figure  1.  Thymocyte fate  in 
the  function  of  the  signal 
strength received  from different 
stromal ceils. Note that the effect 
of the number of individual re- 
ceptor-ligand  interactions  has 
not  been  illustrated.  Adhesion/ 
costimulatory  molecule  interac- 
tions  in  addition  to  those  de- 
picted here probably exist. 
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peptides  interacting with  the  TCR;  (b)  MHC  molecules 
interacting  with  coreceptor  molecules;  and  (c)  adhesion/ 
costimulatory  molecules.  TCR  engagement  seems  to  be 
the crucial event. Both the quality (defined as affinity and/ 
or efficacy) and  quantity of TCR-peptide/MHC  interac- 
tion can determine the survival or death of thymocytes (6, 
48-54). However, in some of these models survival was the 
sole criteria for positive selection, and the responsiveness to 
antigen has not been determined (51,  52).  Although core- 
ceptor molecules have to engage the same MHC molecule 
as the TCR  (55),  overexpression of the coreceptor mole- 
cules  may enhance  negative selection  (56,  57),  suggesting 
that the local concentration of the coreceptor molecule at 
the interface between the immature thymocytes and anti- 
gen presenting cells  may be lower than that of the TCIL. 
Thus, the number of coreceptor molecules engaged in an- 
tigen recognition events may be limiting under normal cir- 
cumstances.  Finally,  stimulation  of thymocytes with  anti- 
CD28 antibody increases the anti-CD3 induced cell death 
of  CD4+CD8 +  thymocytes  (58),  and  interaction  with 
ICAM-1  may be  necessary for in  vitro  deletion  by den- 
dritic cells (59). 
If ICAM-1  expression by Drosophila cells  can  convert 
apoptosis induced by the high affinity ligand for TCR into 
survival, the following question arises:  can cortical epithe- 
lial cells,  that express ICAM-1, but not B7.1, induce toler- 
ance? Cortical epithelial cells likely express additional adhe- 
sion/costimulatory  molecules  that  may  synergize  with 
ICAM-1 to produce signal strength sufficient  to induce apop- 
tosis.  Under  the  physiological  conditions,  therefore,  it 
could be expected that the avidity of the TCR  and core- 
ceptor  interaction  with  the  cortical  epithelial  peptide/ 
MHC complex plays a critical role in determining the out- 
come of interaction- no interaction results in the death by 
default; weak interaction results in positive selection; some- 
what stronger interaction will lead to nondeletional toler- 
ance; and finally, very strong interaction leads to cell death. 
It remains to be determined whether very high strength of 
the signal is ever achieved in the case of cortical epithelial 
cells. Bone marrow-derived cells, best represented by den- 
dritic  cells,  offer so  many adhesion/costimulatory  ligands 
for CD4+CD8 + thymocytes, that even the very low signal 
strength achieved by the TC1L and coreceptor interaction 
with the peptide/MHC complex is given sufficient amplifi- 
cation  to  induce  tolerance  rather  than  positive  selection. 
Medullary epithehum probably provides the range of signal 
strengths  either  equal  to,  or somewhat lower than  those 
provided by dendritic cells, but higher than those provided 
by cortical epithelium. 
There are many aspects of the signal strength model that 
can be tested. One prediction, for example, would be that 
bone marrow-derived cells from B7-deficient mice should 
be more efficient at promoting positive selection than their 
wild-type counterparts. Conversely, B7.1  expressed by the 
thymic  cortical  epithelium  should  reduce  the  potency of 
these  cells  to  induce  positive  selection.  B7.1-transfected 
thymic epithelial cell line was less efficient than its mock- 
transfected  counterpart  in  promoting  the  appearance  of 
CD4-CD8 +  thymocytes  after  intrathymic  injection  into 
[~2-microglobulin-deficient  mice  (60)  offering an  indica- 
tion that the latter prediction may be valid. Some questions 
still  remain open, such as whether survival in the deletion 
assay reflects positive selection or non-deletional tolerance 
and whether signals  imprinting MHC restriction in T  cells 
or differentiation into mature CD4-CD8 + or CD4+CD8 - 
thymocytes are delivered by same cells in the thymus. The 
findings of Kishimoto et al.  (40)  offer a powerful model to 
study the nature ofintracellular signals that mediate survival 
or death of immature CD4+CD8 + thymocytes. 
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